36C25025Q0054.docx
DOCX document 16 KB Posted
- Solicitation number
- 36C25025Q0054
About this file
This document is a Special Notice issued by the Department of Veterans Affairs (VA) announcing the VA's intent to sole source the procurement of TheraSphere Y-90 doses from Boston Scientific.
The VA intends to solicit and negotiate with only Boston Scientific for the TheraSphere Y-90 glass microspheres, a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. The VA cites FAR 13.5 and 41 U.S.C. 1901 as the authority to sole source this requirement, stating that only Boston Scientific can satisfy the agency's needs. Other companies have until October 15, 2024 at 9AM EST to identify their interest and capabilities, which the VA will use to determine if the requirement should be competed. However, the decision to open the procurement to competition is solely at the discretion of the government. No solicitation is currently available, and all inquiries must be submitted by email to the Contracting Officer, Robert Blasko.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SUBJECT*
Supply, TheraSphere Y90 - Nuclear Med, Cleveland
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 44131 |
| SOLICITATION NUMBER* |
| 36C25025Q0054 |
| RESPONSE DATE/TIME/ZONE |
| 10-15-2024 09:00 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 60 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
Network Contracting Office (NCO) 10 6100 Oak Tree Blvd., Suite 490
Independence OH 44131
POINT OF CONTACT*
Contracting Officer Robert Blasko robert.blasko@va.gov 216-447-8300
ADDITIONAL INFORMATION
| AGENCY’S URL |
| http://www.va.gov |
| URL DESCRIPTION |
| VA home page |
| AGENCY CONTACT’S EMAIL ADDRESS |
| robert.blasko@va.gov |
| EMAIL DESCRIPTION |
| Contracting Officer |
Special Notice Special Notice
DESCRIPTION
| *= Required Field |
| Special Notice |
Special Notice
36C25025Q0054
SPECIAL NOTICE
NOTICE OF INTENT TO SOLE SOURCE
TheraSphere Y-90 Nuclear Med
The Department of Veterans Affairs, The Louis Stokes Cleveland Department of Veteran Affairs Medical Center, 10701 East Boulevard, Cleveland, Ohio 44106 intends to solicit and negotiate with only one source under the authority of FAR 13.5 and 41 U.S.C. § 1901 as implemented by FAR 13.106-1(b)(2), “Only one responsible source and no other supplies or services will satisfy agency requirements.” The VA intends to solicit and negotiate with Boston Scientific, 300 Boston Scientific Way, Marlborough, MA 01752, for TheraSphere Y-90 Doses.
TheraSphere, Y-90 glass microsphere is a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. It consists of microscopic glass spheres that are attached to a radioactive isotope (Y-90) and then injected into the patient. The spheres are trapped in the liver where they can treat liver cancer.
The Government believes that only one business can satisfy the agency requirements and intends to negotiate with only one source under the authority of FAR 13.5 and 41 U.S.C. § 1901 as implemented by FAR 13.106-1(b)(2), “Only one responsible source and no other supplies or services will satisfy agency requirements.” Other persons may identify their interest and capability to respond to this requirement by Tuesday, October 15, 2024 at 9AM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time. All inquiries must be submitted by email to Robert Blasko at robert.blasko@va.gov Enter “RFQ 36C25025Q0054 TheraSphere Y-90 Nuclear Med” in the email subject line.
Page 1 of
File details come from the government source that posted it. Updated .